Experimental pill tested to shrink dangerous blood vessel tangles
NCT ID NCT05125471
Summary
This study tested whether a drug called cobimetinib, taken as a daily pill for 3 weeks at a time, is safe and can shrink abnormal tangles of blood vessels located outside the brain (extracranial arteriovenous malformations). It involved a very small group of 3 participants, aged 2 to 80, who had these difficult-to-treat lesions. The main goal was to see if the drug could reduce the size of the malformation by at least 20%.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARTERIOVENOUS MALFORMATIONS (EXTRACRANIAL) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Arkansas Children's Hospital
Little Rock, Arkansas, 72202, United States
Conditions
Explore the condition pages connected to this study.